1. Home /
  2. Pharmaceuticals


Zoetis Stock Has More Room to Run

ZTS is in a longer-term uptrend that should continue when the weakness in the broader market subsides.

Novavax Rallies and Turns the Charts More Positive

I like the risk/reward set up now.

Vertex Pharmaceuticals Is Rallying and Gets a Quant Upgrade

The stock has broken a long-term downtrend, which gets my attention.

CVS Health Nears Our Longer-Term Price Target

We now have two new price targets.

We See Multiple Boosts Ahead for Pfizer

We have new price targets for soaring shares of PFE. Let's check the charts.

The Bedraggled Biotech Sector Finally Offers a Glimmer of Hope

Two recent acquisition deals and big drug companies that are flush with cash provide reason to believe biotech stocks could rebound in 2022

Regeneron Is Regenerating Its Uptrend

Here's how aggressive traders could play this biotech giant -- and our targets for the name.

The Final 4 Bedraggled Stocks for My 2022 Tax Loss Selling Recovery Portfolio

This quartet has had a rough 2021 but could be in for a rebound next year once investors harvest their losses in the shares.

Our Updated Strategy as AbbVie Finally Breaks Out to New Highs

The bulls are back in charge.

UnitedHealth Group's Charts Continue to Point Higher

Here's our next price target.